Table 4.

The five-fold cross-validation performance of MAN-HOPE for predicting miRNA-disease associations.

Fold	Acc. (%)	Sen. (%)	Spec. (%)	Prec. (%)	MCC (%)	AUC (%)
0	86.32	82.14	90.51	89.64	72.9	92.14
1	85.48	81.65	89.32	88.43	71.18	92.17
2	85.86	81.53	90.2	89.27	72	92.04
3	85.56	80.74	90.38	89.36	71.45	91.73
4	86.23	82.3	90.16	89.32	72.69	92.13
Average	85.89 ± 0.38	81.67 ± 0.61	90.11 ± 0.47	89.20 ± 0.46	72.04 ± 0.75	92.04 ± 0.18

The boldface indicates this measure performance is the best in this item among the compared methods.